CAS 611227-74-8

Formule : C27H32N4O4

InChI : InChI=1S/C27H32N4O4/c1-17(2)14-24(25(32)30-34)31-13-12-27(28,26(31)33)20-8-10-21(11-9-20)35-16-19-15-18(3)29-23-7-5-4-6-22(19)23/h4-11,15,17,24,34H,12-14,16,28H2,1-3H3,(H,30,32)/t24-,27-/m1/s1

Code InChI : QVNZBDLTUKCPGJ-SHQCIBLASA-N

SMILES : CC1=NC2=CC=CC=C2C(=C1)COC3=CC=C(C=C3)[C@@]4(CCN(C4=O)[C@H](CC(C)C)C(=O)NO)N

BMS 561392

Produit contrôlé

CAS : 611227-74-8

Formule : C₂₇H₃₂N₄O₄

Couleur et forme : Neat

Masse moléculaire : 476.567

Ref: TR-B596200

BMS-561392

CAS : 611227-74-8

BMS-561392 (DPC333) is a tumor necrosis factor-α ( TNF-α) Invertase inhibitor.

Formule : C₂₇H₃₂N₄O₄

Degré de pureté : 99.16%

Couleur et forme : Solid

Masse moléculaire : 476.57

Ref: TM-T30531

BMS 561392

CAS : 611227-74-8

BMS 561392 is an analog inhibitor that has demonstrated potent anticancer activity in human cancer cells. It is a kinase inhibitor that targets multiple kinases involved in tumor growth and progression. BMS 561392 has been shown to induce apoptosis in cancer cells and inhibit the growth of tumors. This compound has been tested in Chinese hamster ovary cells, where it was found to be a potent inhibitor of protein kinases. In addition, BMS 561392 has been shown to enhance the effects of nintedanib, another anticancer drug, when used in combination therapy. Its unique mechanism of action makes it a promising candidate for the development of new cancer therapies.

Formule : C₂₇H₃₂N₄O₄

Degré de pureté : Min. 95%

Masse moléculaire : 476.6 g/mol

Ref: 3D-LZA22774